Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ulrich

Showing results (281-290 of 294) with videos related to

Pageof 30
Sort By:
Vaccine|November 23, 2025
Funding the priorities of the influenza vaccines research and development roadmap: an evaluation of global investmentAngela K Ulrich, Lauren Bigalke, Meredith Arpey, et al.
The Journal of Biological Chemistry|April 10, 2023
Short-term CaMKII inhibition with tatCN19o does not erase pre-formed memory in mice and is neuroprotective in pigsNicole L Rumian, Carolyn Nicole Brown, Tara B Hendry-Hofer, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Short-term CaMKII inhibition with tatCN19o does not erase pre-formed memory and is neuroprotective in non-rodentsNicole L Rumian, Carolyn Nicole Brown, Tara B Hendry-Hofer, et al.
The Journal of Biological Chemistry|June 16, 2010
Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complexKrishna Saxena, Ulrich Schieborr, Oliver Anderka, et al.
Vaccine|July 2, 2025
Accomplishments and challenges in developing improved influenza vaccines: An evaluation of three years of progress toward the milestones of the influenza vaccines research and development roadmapJulia T Ostrowsky, Natalie C Vestin, Angela J Mehr, et al.
Vaccine|March 4, 2023
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategyKristine A Moore, Tabitha Leighton, Julia T Ostrowsky, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and developmentJulia T Ostrowsky, Leah C Katzelnick, Nigel Bourne, et al.
The New England Journal of Medicine|October 29, 2025
Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026Jake Scott, Michael S Abers, Harleen K Marwah, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus: advancing a priority research agenda for preparedness and responseEve M Lackritz, Lee-Ching Ng, Ernesto T A Marques, et al.
The Lancet. Infectious Diseases|July 4, 2024
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29Kristine A Moore, Angela J Mehr, Julia T Ostrowsky, et al.
Pageof 30

Showing results (281-290 of 294) with videos related to

Sort By:
Pageof 30
Vaccine|November 23, 2025
Funding the priorities of the influenza vaccines research and development roadmap: an evaluation of global investmentAngela K Ulrich, Lauren Bigalke, Meredith Arpey, et al.
The Journal of Biological Chemistry|April 10, 2023
Short-term CaMKII inhibition with tatCN19o does not erase pre-formed memory in mice and is neuroprotective in pigsNicole L Rumian, Carolyn Nicole Brown, Tara B Hendry-Hofer, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Short-term CaMKII inhibition with tatCN19o does not erase pre-formed memory and is neuroprotective in non-rodentsNicole L Rumian, Carolyn Nicole Brown, Tara B Hendry-Hofer, et al.
The Journal of Biological Chemistry|June 16, 2010
Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complexKrishna Saxena, Ulrich Schieborr, Oliver Anderka, et al.
Vaccine|July 2, 2025
Accomplishments and challenges in developing improved influenza vaccines: An evaluation of three years of progress toward the milestones of the influenza vaccines research and development roadmapJulia T Ostrowsky, Natalie C Vestin, Angela J Mehr, et al.
Vaccine|March 4, 2023
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategyKristine A Moore, Tabitha Leighton, Julia T Ostrowsky, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and developmentJulia T Ostrowsky, Leah C Katzelnick, Nigel Bourne, et al.
The New England Journal of Medicine|October 29, 2025
Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026Jake Scott, Michael S Abers, Harleen K Marwah, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus: advancing a priority research agenda for preparedness and responseEve M Lackritz, Lee-Ching Ng, Ernesto T A Marques, et al.
The Lancet. Infectious Diseases|July 4, 2024
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29Kristine A Moore, Angela J Mehr, Julia T Ostrowsky, et al.
Pageof 30